Later studies were unable to confirm key elements of these data [e.g. 11], [12]–[14], and subsequent analysis of mice carrying a targeted deletion of the TSG101 gene found no effect on cancer incidence or progression but did reveal a requirement for embryonic viability [15], [16]. The gene discussed is TSG101; the disease is cancer.